Annual Cash & Cash Equivalents
$76.06 M
+$31.44 M+70.45%
May 31, 2024
Summary
- As of February 8, 2025, ANGO annual cash & cash equivalents is $76.06 million, with the most recent change of +$31.44 million (+70.45%) on May 31, 2024.
- During the last 3 years, ANGO annual cash & cash equivalents has risen by +$27.89 million (+57.92%).
- ANGO annual cash & cash equivalents is now -66.59% below its all-time high of $227.64 million, reached on May 31, 2019.
Performance
ANGO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$54.09 M
-$916.00 K-1.67%
November 30, 2024
Summary
- As of February 8, 2025, ANGO quarterly cash and cash equivalents is $54.09 million, with the most recent change of -$916.00 thousand (-1.67%) on November 30, 2024.
- Over the past year, ANGO quarterly cash and cash equivalents has dropped by -$21.97 million (-28.88%).
- ANGO quarterly cash and cash equivalents is now -76.24% below its all-time high of $227.64 million, reached on May 31, 2019.
Performance
ANGO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANGO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.5% | -28.9% |
| 3 y3 years | +57.9% | +57.7% |
| 5 y5 years | -66.6% | +31.1% |
ANGO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +163.8% | -31.1% | +126.4% |
| 5 y | 5-year | -66.6% | +163.8% | -31.1% | +126.4% |
| alltime | all time | -66.6% | +7999.7% | -76.2% | +5660.3% |
AngioDynamics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $54.09 M(-1.7%) |
| Aug 2024 | - | $55.01 M(-27.7%) |
| May 2024 | $76.06 M(+70.5%) | $76.06 M(-3.1%) |
| Feb 2024 | - | $78.45 M(+28.8%) |
| Nov 2023 | - | $60.90 M(+5.7%) |
| Aug 2023 | - | $57.59 M(+29.1%) |
| May 2023 | $44.62 M(+54.8%) | $44.62 M(+48.2%) |
| Feb 2023 | - | $30.11 M(+0.9%) |
| Nov 2022 | - | $29.86 M(+21.5%) |
| Aug 2022 | - | $24.56 M(-14.8%) |
| May 2022 | - | $28.82 M(+20.7%) |
| May 2022 | $28.82 M(-40.1%) | - |
| Feb 2022 | - | $23.89 M(-30.3%) |
| Nov 2021 | - | $34.29 M(-3.3%) |
| Aug 2021 | - | $35.47 M(-26.3%) |
| May 2021 | $48.16 M(-11.5%) | $48.16 M(-11.6%) |
| Feb 2021 | - | $54.47 M(-6.1%) |
| Nov 2020 | - | $58.02 M(+21.1%) |
| Aug 2020 | - | $47.93 M(-12.0%) |
| May 2020 | $54.44 M(-76.1%) | $54.44 M(+100.4%) |
| Feb 2020 | - | $27.16 M(-34.2%) |
| Nov 2019 | - | $41.25 M(-50.7%) |
| Aug 2019 | - | $83.65 M(-63.3%) |
| May 2019 | $227.64 M(+207.2%) | $227.64 M(+445.8%) |
| Feb 2019 | - | $41.70 M(-2.6%) |
| Nov 2018 | - | $42.82 M(+72.9%) |
| Aug 2018 | - | $24.76 M(-66.6%) |
| May 2018 | $74.10 M(+55.8%) | $74.10 M(+41.7%) |
| Feb 2018 | - | $52.29 M(+4.9%) |
| Nov 2017 | - | $49.86 M(+3.4%) |
| Aug 2017 | - | $48.20 M(+1.4%) |
| May 2017 | $47.54 M(+47.0%) | $47.54 M(+33.7%) |
| Feb 2017 | - | $35.57 M(-0.3%) |
| Nov 2016 | - | $35.66 M(-4.7%) |
| Aug 2016 | - | $37.41 M(+15.7%) |
| May 2016 | $32.33 M(+75.8%) | $32.33 M(+47.7%) |
| Feb 2016 | - | $21.90 M(+15.3%) |
| Nov 2015 | - | $19.00 M(-6.3%) |
| Aug 2015 | - | $20.27 M(+10.2%) |
| May 2015 | $18.39 M(+14.2%) | $18.39 M(-6.7%) |
| Feb 2015 | - | $19.70 M(+32.4%) |
| Nov 2014 | - | $14.88 M(+7.7%) |
| Aug 2014 | - | $13.81 M(-14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2014 | $16.11 M(-26.1%) | $16.11 M(+118.2%) |
| Feb 2014 | - | $7.38 M(-51.3%) |
| Nov 2013 | - | $15.17 M(-31.2%) |
| Aug 2013 | - | $22.07 M(+1.2%) |
| May 2013 | $21.80 M(-7.3%) | $21.80 M(+31.1%) |
| Feb 2013 | - | $16.63 M(-14.0%) |
| Nov 2012 | - | $19.32 M(+2.3%) |
| Aug 2012 | - | $18.90 M(-19.6%) |
| May 2012 | $23.51 M(-48.9%) | $23.51 M(-31.0%) |
| Feb 2012 | - | $34.05 M(-20.7%) |
| Nov 2011 | - | $42.95 M(-14.9%) |
| Aug 2011 | - | $50.49 M(+9.8%) |
| May 2011 | $45.98 M(-21.7%) | $45.98 M(+30.4%) |
| Feb 2011 | - | $35.26 M(+29.9%) |
| Nov 2010 | - | $27.13 M(-59.6%) |
| Aug 2010 | - | $67.20 M(+14.4%) |
| May 2010 | $58.76 M(+110.6%) | $58.76 M(+56.6%) |
| Feb 2010 | - | $37.51 M(+3.5%) |
| Nov 2009 | - | $36.26 M(+12.7%) |
| Aug 2009 | - | $32.17 M(+15.3%) |
| May 2009 | $27.91 M(-12.9%) | $27.91 M(+4.2%) |
| Feb 2009 | - | $26.78 M(+35.7%) |
| Nov 2008 | - | $19.73 M(+6.6%) |
| Aug 2008 | - | $18.52 M(-42.2%) |
| May 2008 | $32.04 M(+13.2%) | $32.04 M(-26.6%) |
| Feb 2008 | - | $43.65 M(+91.8%) |
| Nov 2007 | - | $22.76 M(-2.8%) |
| Aug 2007 | - | $23.43 M(-17.3%) |
| May 2007 | $28.31 M(-55.8%) | $28.31 M(-25.6%) |
| Feb 2007 | - | $38.05 M(-48.0%) |
| Nov 2006 | - | $73.16 M(+3.4%) |
| Aug 2006 | - | $70.79 M(+10.5%) |
| May 2006 | $64.04 M(+341.7%) | $64.04 M(+379.5%) |
| Feb 2006 | - | $13.36 M(+2.4%) |
| Nov 2005 | - | $13.04 M(-1.9%) |
| Aug 2005 | - | $13.30 M(-8.3%) |
| May 2005 | $14.50 M(+729.9%) | $14.50 M(-5.9%) |
| Feb 2005 | - | $15.40 M(+30.0%) |
| Nov 2004 | - | $11.85 M(-42.9%) |
| Aug 2004 | - | $20.75 M(+1087.7%) |
| May 2004 | $1.75 M(+86.0%) | $1.75 M(+31.2%) |
| Feb 2004 | - | $1.33 M(+41.9%) |
| May 2003 | $939.00 K(-38.4%) | $939.00 K |
| May 2002 | $1.52 M | - |
FAQ
- What is AngioDynamics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AngioDynamics?
- What is AngioDynamics annual cash & cash equivalents year-on-year change?
- What is AngioDynamics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AngioDynamics?
- What is AngioDynamics quarterly cash and cash equivalents year-on-year change?
What is AngioDynamics annual cash & cash equivalents?
The current annual cash & cash equivalents of ANGO is $76.06 M
What is the all time high annual cash & cash equivalents for AngioDynamics?
AngioDynamics all-time high annual cash & cash equivalents is $227.64 M
What is AngioDynamics annual cash & cash equivalents year-on-year change?
Over the past year, ANGO annual cash & cash equivalents has changed by +$31.44 M (+70.45%)
What is AngioDynamics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANGO is $54.09 M
What is the all time high quarterly cash and cash equivalents for AngioDynamics?
AngioDynamics all-time high quarterly cash and cash equivalents is $227.64 M
What is AngioDynamics quarterly cash and cash equivalents year-on-year change?
Over the past year, ANGO quarterly cash and cash equivalents has changed by -$21.97 M (-28.88%)